DAFTAR PUSTAKA

1. Katzung, Bertram G. 2010. Farmakologi Dasar dan Klinik. Edisi 10. Jakarta:
Penerbit Buku Kedokteran EGC.
2. Prusty, A.K dan Sahu, S.K., 2009, Biodegradable Nanoparticles- A Novel
Approach for Oral Administration of Biological Products, International
Journal of Pharmaceutical Sciences and Nanotechnology 2(2) : 503-508.
3. Nurlita, Nunuk A., Siswanto, A. 2007. Efek Sitotoksik dan Antiproliferatif
Ekstrak Kloroform Buah Mahkota Dewa terhadap Sel Kanker Payudara
T47D. Jurnal Farmasi Indonesia, Vol. 3 No. 4 : 168-175.
4. Gupta, R.B., Kompella, U. B. 2006. Nanoparticle Drug Delivery for
Technology. New York: Taylor & Francis Group.
5. Vinagradov, S.V., Bronich, T.K., Kabanov, A.V., 2002, Nanosized Cationic
Hydrogels for Drug Delivery: Preparation, Properties and Interactions with
Cells, Adv. Drug Del. Rev. 54, 223233.
6. Desai, M.P., Labhasetwar, V., Amidon, G.L., Levy, R.J., 1996, Gastrointestinal
Uptake of Biodegradable Microparticles: Effect of Particle Size, Pharm. Res.,
13, 18381845.
7. Moghimi, S.M., Hunter, A.C., Murray, J.C., 2001, Long-circulating, and
Target Specific Nanoparticles: Theory to Practice, Pharmacol. Rev. 53, 283
318.
8. Buzea, C., Blandino, I.I.P., and Robbie, K. 2007. Nanomaterials and
Nanoparticles: Sources and Toxicity. Biointerphases. 2(4): 17-172.
9. Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., dan. Rudzinski, W.E.
2001. Biodegradable Polymeric Nanoparticles as Drug Delivery Devices.
Journal of Controlled Release. 20: 1-20.
10. Mansouri, M., Pouretedal, H.R., dan Vosough, V. 2011. Preparation and
Characterization of Ibuprofen Nanoparticles by Using Solvent/Antisolvent
Precipitation. The Open Conference Proceeding Journal. 2: 88-94.
11. Haskel, R. 2009. Nanotechnology in Drug Discovery and Development.
Bristol: Myers Squibb.
12. Junghanns, J.U.A.H., and Mller, R.H. 2008. Nanocrystal Technology, Drug
Delivery and Clinical Applications. International Journal Nanomedicine. 3(3):
295-309.

28

29

13. Vijaykumar, N., Venkateswarlu, V., dan Raviraj, P. 2010. Development of Oral
Tablet Dosage Form Incorporating Drug Nanoparticles. Research Journal of
Pharmaceutical, Biological and Chemical Sciences. 1(4): 952-955
14. Narayan, P. S., Pooja, S., Khushboo, A., Diwakar, T., Ankit, S., Singhai, A. K.
2010. Dendrimers A Novel Drug Delivery System. International Journal of
Pharmacy and Life Sciences, 382-388.
15. Nanjwade, B. K., Bechra, H. M., Derkar, G. K., Manvi, F. V., Nanjwade, V. K.
2009. Dendrimers: Emerging Polymers for Drug-Delivery System. European
Journal of Pharmaceutical Sciences, 185-196.
16. Toraskar, M. P., Pande, V. G., Kadam, V. J. 2011. Dendrimer: A New
Approach in Pharmacy. International Journal of Research in Pharmacy and
Chemistry 1(4), 1100-1107.
17. Sharma, K., Pfister, W.R. dan T.K. Ghosh. 2005. Quick-Dispersing Oral Drug
Delivery Systems. In: T.K. Ghosh dan W.R. Pfister (eds). Drug Delivery to
The Oral Cavity: Molecules to Market. Boca Raton: Taylor & Francis Group.
Pages 262-263.
18. Rao, N.G.R., Patel, T. dan S. Gandhi. 2009. Development and Evaluation of
Carbamazepine Fast Dissolving Tablets Prepared with A Complex by Direct
Compression Technique. Asian J. Pharma. April-June.3(2):97-103.
19. Koseki, T., Onishi, H., Takahashi, Y., Uchida, M. dan Y. Machida. 2008.
Development of Novel Fast-Disintegrating Tablets by Direct Compression
Using Sucrose Stearic Acid Esters as A Disintegration-Accelerating Agent.
Chem. Pharm. Bull. 56(10): 1384-1388.
20. Kaushik, D., Dureja, H. dan T.R. Saini. 2004. Orally Disintegrating Tablets:
An Overview of Melt-in-Mouth Tablets Technologies and Techniques.
http://www.tabletscapsules.com/Content/getArticle.aspx?ItemID=26f20a9d8eb5-4b9e-816b-e6650cb23519&AuthorID=b46f675c-c322-40dd-8e9325c9de9dad8&Author=Kaushik,+Deepak
21. Kundu, S. dan P.K. Sahoo. 2008. Recent Trends in The Developments of
Orally Disintegrating Tablet Technology. Pharma Times 40(4): 11-21.
22. Fu, Y.R., Yang, S.C., Seong, H.J., Kimura, S. dan K. Park. 2004. Orally Fast
Disintegrating Tablets: Developments, Technologies, Taste-Making and
Clinical Studies. Therapeutic Drug Carrier Systems 21(6): 433-475.
23. Verma, R.K. dan S. Garg. 2001. Current Status of Drug Delivery Technologies
and Future Directions. Pharmaceutical Technology On-Line 25(2): 1-14.

30

24. Ghost, T.K., Chatterjee, D.J., Pfister, W.R., Jarugula, V.R., Fadiran, E.O.,
Hunt, J.P., Lesko, L.J., Tammara, V.K. dan D.B. Hare. 2005. Quick Dissolving
Oral Dosage Forms: Scientific and Regulatory Considerations from A Clinical
Pharmacology and Biopharmaceutics Perspective. In: T.K. Ghosh dan W.R.
Pfister (eds). Drug Delivery to The Oral Cavity: Molecules to Market. Boca
Raton: Taylor & Francis Group. Page 344.
25. Shukla, D., Chakraborty, S., Singh, S. dan B. Mishra. 2009. Mouth Dissolving
Tablets I: An Overview of Formulation Technology. Sci. Pharm. 76: 309-326.
26. Goel, H., Rai, P., Rana, V. dan A.K. Tiwary. 2008. Orally Disintegrating
Systems: Innovations in Formulation and Technology. Recent Pat. Drug Deliv.
Formul. 2(3): 258-274.
27. Harmanto, Ning. 2001. Mahkota Dewa Obat Pusaka Para Dewa. AgroMedia
Pustaka. Jakarta.
28. Dalimartha, Setiawan. 2003. Atlas Tumbuhan Obat Indonesia. Jilid 3. Puspa
Swara. Jakarta.
29. Dalimartha, Setiawan. 2004. Deteksi

Dini

Kanker

dan

Simplisia

Antikanker. Penebar Swadaya. Jakarta.

30. Gotama, IBI, Sugiarto, S., Nurhadi, M., Widiyastuti, Y. Wahyono, S. Dan
Prapti, IJ 1999. Inventaris Tanaman Obat Indonesia. Jilid V. Jakarta,
Departemen Kes. Badan Penelitian dan Pengembangan Kesehatan.
31. De PLS, Bunyapraphatsara N, Lemmens RHMS. 1999. Plant resources of
south east asia. medical and poisonous plants. Printed in Bogor Indonesia
(PROSEA). Leyden: Backhuys Publishers.
32. Hartati SM, Sofia M, Gandjar IG, Hamann, MT, Rao KV, Wahyuono S. 2005.
Phalerin, glukosida benzophenon baru diisolasi dari ekstrak metanolik dan
mahkota dewa [Phaleria macrocarpa (Scheff). Boerl.]. Majalah Farmasi
Indonesia 16(1):51-7.
33. Tambunan R, Simanjuntak P. Penentuan struktur kimia antioksidan
benzofenon glikosida dari ekstrak n-butanol buah mahkota dewa {Phaleria
macrocarpa (Scheff) Boerl.)}. Majalah Farmasi Indonesia 17(4):1849.
34. Astuti E, Raharjo TJ, Eviane D. Yogyakarta Indonesia: Proceeding of
International Conference On Chemical Sciences; 2007. Cytotoxicity of
Phaleria macrocarpa (Scheff) boerl fruit flesh and seed extract of ethanol and
its effect against p53 and Bcl-2 genes expression of normal cell

31

35. Agung BS, Faried A, Arifin MZ, Wiriadisastra K, Ohta T. Herbal Medicine
Isolation, Phaleria macrocarpa for primary glioblastoma multiforme cells. Ann
Epidemiol. 2008;18:70841.
36. Lu Y, Jiang F, Jiang H, Wu K, Zheng X, Cai Y, et al. Gallic acid suppresses
cell viability, proliferation, invasion and angiogenesis in human glioma cells.
Eur J Pharmacol. 2010;641:1027.
37. Riwanto I, Budijitno S, Dharmana E, Handojo D, Prasetyo SA, Eko A, et al.
Effect of phaleria macrocarpa supplementation on apoptosis and tumor growth
of C3H mice with breast cancer under treatment with adriamycincyclophosphamide. Int Surg. 2011;96:16470.
38. Tjandrawinata RR, Arifin PF, Tandrasasmita OM, Rahmi D, Aripin A.
DLBS1425, a Phaleria macrocarpa (Scheff.) Boerl. extract confers anti
proliferative and proapoptosis effects via eicosanoid pathway. J Exp Ther
Oncol. 2010;8:187201.
39. Tjindarbumi, 1995. Diagnosis dan Pencegahan Kanker Payudara, Kursus
Singkat Deteksi Dini dan Pencegahan Kanker. 6-8 November. FKC.II-POI.
Jakarta.
40. Moningkey, S.I., 2000. Epidemiologi Kanker Payudara. Medika; Januari
2000.Jakarta.
41. Ambarsari, E., 1998. Faktor-faktor Risiko Kanker Payudara di RSU
Persahabatan, Jakarta pada Juni sampai September 1997. UI. Depok.
42. Rasjidi, Imam, dan Hartanto, Andree, 2009. Kanker Payudara. Dalam: Rasjidi,
Imam, ed. Deteksi Dini dan Pencegahan Kanker Pada Wanita. Jakarta :
Sagung Seto, 51-91.
43. Suryaningsih, E. K., dan Sukaca, B. E., 2009. Gejala-Gejala Kanker Payudara.
Dalam: Suryaningsih, E. K., dan Sukaca, B. E., ed. Kanker Payudara.
Yogyakarta : Paradigma Indonesia, 35-36.
44. Rowe, R, C., Sheskey, P.J., dan Weller, P.J. 2003. Handbook of
Pharmaceutical Excipients. Edisi IV. London: Publisher-Science and Practice
Royal Pharmaceutical Society of Great Britain.
45. Lachman, L., Liebermann, H.A., dan. Kanig, J.I. 1994. Teori and Praktek
Farmasi Industri II. Edisi III. Jakarta: UI Press.
46. Bertolini, Andrea C. 2010. Trends in Starch Application. Dalam: Andrea C.
Bertolini. Starch: Characterization, Properties, and Applications. Boca Raton:
CRC Press Taylor & Francis Group, LLC, 1-6.

32

47. Perez, S., Baldwin, P.M., & Gallant, D.J. 2009. Structural Features of Starch
Granules. Dalam: J. BeMiller & R. Whistler. Starch Chemistry and
Technology. 3rd Edition. New York: Academic Press, Elsevier Inc, 149-192.
48. Lay, Ma Ma, Karsani, S. A., Mohajer, S., Malek, S. N. A. 2014.
Phytochemical Constituents, Nutritional Values, Phenolics, Flavonol,
Flavanoids, Antioxidant and Cytotoxicity Studies on Phaleria macrocarpa
(Scheff.) Boerl Fruits. BMC Complementary and Alternative Medicine 2014,
14:152.
49. Markatou, E., Gionis, V., Chryssikos, G. D., Hatziantoniou, S., Georgopoulos,
A., Demetzos, C. 2007. Molecular Interaction Between Dimethoxycurcumin
and PAMAM Dendrimer Carriers. International Journal of Pharmaceutics 339,
231-236.
50. Lanimarta, Yurika. 2012. Pembuatan dan Uji Penetrasi Nanopartikel
Kurkumin-Dendrimer Poliamidoamin (PAMAM) Generasi 4 dalam Sediaan
Gel dengan Menggunakan Sel Difusi Franz. Skripsi. Depok: UI.
51. Anwar, E., Antokalina, S.V., Harianto. 2006. Pati Pregel Pati Singkong Fosfat
sebagai Bahan Pensuspensi Sirup Kering Ampisilin. Majalah Ilmu
Kefarmasian, 3(3), 117-126.
52. Billmers, R.L., Tessler, M.M. 1994. Method of Preparing Intermediate DS
Starch Esthers in Aqueous Solution. US Patent: 5, 123, 321.
53. Ditjen POM. 1995. Farmakope Indonesia Edisi IV. Jakarta: Departemen
Kesehatan Republik Indonesia.
54. Ansel, H.C. 1989. Pengantar Bentuk Sediaan Farmasi. Edisi IV. Jakarta: UI
Press.
55. Rawas-Qalaji, Mutasem M., Estelle, F., Simons, R., dan Simons, Keith J.

2006. Fast-Disintegrating Sublingual Tablet: Effect of Epinephrine Load on

Tablet Characteristics. AAPS Pharm. Sci. Tech, 72-78.